BioSpace News Archive

Morinaga Milk Industry Co., Ltd. hereby announces that its subsidiary MILEI GmbH, which has the largest share* of the global market in terms of production volume of the functional ingredient lactoferrin, will increase more than double its production capacity with the aim to enhance its lactoferrin production. * According to data for 2019 released by Absolute Reports.

PureTech Health plc, a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, announces that it has filed a public Registration Statement on Form 20-F to the United States Securities and Exchange Commission in conjunction with a potential listing of American Depository Shares on the Nasdaq Stock Market.

BioArctic AB announced that the company’s partner Eisai will conduct four oral presentations related to the drug candidate BAN2401 at the 13th Clinical Trials on Alzheimer’s Disease Conference on November 4-7.

TLC, a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need, announced financial results for the third quarter ending September 30, 2020, and provided a business update.

The Chief Executive Officer for BetterLife Pharma Inc., an emerging biotechnology company currently preparing for clinical trials of AP-003, its interferon alpha 2b COVID-19 treatment, joined investor portal Proactive to discuss the key differences between the interferon inhalation formula used by BetterLife against that used successfully by Synairgen PLC.

Biodesix, Inc. announced the pricing of its initial public offering of 4,000,000 shares of its common stock at a public offering price of $18.00 per share.

Dr. Reddy’s Laboratories Ltd. announced its consolidated financial results for the quarter and the half year ended September 30, 2020.

Third quarter Orenitram® net revenue growth of 20% and Tyvaso® net revenue growth of 17% year-over-year

Dr. Reddy’s Laboratories Ltd. announced that Parag Agarwal will be joining the Company as Chief Financial Officer on November 2, 2020.

ChromaDex Corp. announced that it will hold a conference call on Wed., November 4, 2020 at 4:30 p.m. ET to discuss its financial results for the third quarter ended September 30, 2020.